Natasha K Stout

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography
    Natasha K Stout
    Affiliations of authors Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA NKS Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA SJL, HH Departments of Family and Social Medicine and Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY CBS Departments of Epidemiology and Biostatistics, and General Internal Medicine Section, Department of Veterans Affairs, University of California, San Francisco, CA KK Department of Industrial and Systems Engineering OA, MC and Department of Population Health Sciences and Carbone Cancer Center OA, AT D, University of Wisconsin, Madison, WI Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX DB, GC, MFM Group Health Research Institute, Seattle, WA DSMB, RAH Department of Public Health, Erasmus MC, Rotterdam, The Netherlands HJdK, NTvR Department of Public Health Sciences, School of Medicine, University of California, Davis, California DLM Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH ANAT Department of Oncology, Georgetown University Medical Center and Cancer Prevention and Control Program, Department of Surgery
    J Natl Cancer Inst 106:dju092. 2014
  2. pmc Early uptake of breast magnetic resonance imaging in a community-based medical practice, 2000-2004
    Natasha K Stout
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA
    J Womens Health (Larchmt) 20:631-4. 2011
  3. pmc Calibration methods used in cancer simulation models and suggested reporting guidelines
    Natasha K Stout
    Department of Ambulatory Care and Prevention, Harvard Medical School Harvard Pilgrim Health Care, Boston, Massachusetts 02215, USA
    Pharmacoeconomics 27:533-45. 2009
  4. pmc Trade-offs in cervical cancer prevention: balancing benefits and risks
    Natasha K Stout
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Ave, Second Floor, Boston, MA 02115, USA
    Arch Intern Med 168:1881-9. 2008
  5. pmc Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis
    Nataliya G Batina
    Department of Industrial and Systems Engineering, University of Wisconsin, 1513 University Avenue, Madison, WI 53706, USA
    Breast Cancer Res Treat 138:519-28. 2013
  6. pmc Cost-effectiveness of digital mammography breast cancer screening
    Anna N A Tosteson
    The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth Medical School, Lebanon, New Hampshire 03756, USA
    Ann Intern Med 148:1-10. 2008
  7. doi request reprint Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011
    Natasha K Stout
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts
    JAMA Intern Med 174:114-21. 2014
  8. ncbi request reprint Retrospective cost-effectiveness analysis of screening mammography
    Natasha K Stout
    Center for Risk Analysis, Harvard School of Public Health, Boston, MA 02115, USA
    J Natl Cancer Inst 98:774-82. 2006
  9. pmc Keeping the noise down: common random numbers for disease simulation modeling
    Natasha K Stout
    Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Ave, Boston, MA 02115, USA
    Health Care Manag Sci 11:399-406. 2008
  10. pmc Modeling the effectiveness of initial management strategies for ductal carcinoma in situ
    Djøra I Soeteman
    Center for Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
    J Natl Cancer Inst 105:774-81. 2013

Detail Information

Publications15

  1. ncbi request reprint Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography
    Natasha K Stout
    Affiliations of authors Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA NKS Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA SJL, HH Departments of Family and Social Medicine and Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY CBS Departments of Epidemiology and Biostatistics, and General Internal Medicine Section, Department of Veterans Affairs, University of California, San Francisco, CA KK Department of Industrial and Systems Engineering OA, MC and Department of Population Health Sciences and Carbone Cancer Center OA, AT D, University of Wisconsin, Madison, WI Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX DB, GC, MFM Group Health Research Institute, Seattle, WA DSMB, RAH Department of Public Health, Erasmus MC, Rotterdam, The Netherlands HJdK, NTvR Department of Public Health Sciences, School of Medicine, University of California, Davis, California DLM Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH ANAT Department of Oncology, Georgetown University Medical Center and Cancer Prevention and Control Program, Department of Surgery
    J Natl Cancer Inst 106:dju092. 2014
    ..Digital has replaced film in virtually all US facilities, but overall population health and cost from use of this technology are unclear...
  2. pmc Early uptake of breast magnetic resonance imaging in a community-based medical practice, 2000-2004
    Natasha K Stout
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA
    J Womens Health (Larchmt) 20:631-4. 2011
    ..Use appears to be growing, although evidence for or against its use is still accumulating...
  3. pmc Calibration methods used in cancer simulation models and suggested reporting guidelines
    Natasha K Stout
    Department of Ambulatory Care and Prevention, Harvard Medical School Harvard Pilgrim Health Care, Boston, Massachusetts 02215, USA
    Pharmacoeconomics 27:533-45. 2009
    ..To aid peer-review and facilitate discussion of modelling methods, we propose a standardized Calibration Reporting Checklist for model documentation...
  4. pmc Trade-offs in cervical cancer prevention: balancing benefits and risks
    Natasha K Stout
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Ave, Second Floor, Boston, MA 02115, USA
    Arch Intern Med 168:1881-9. 2008
    ....
  5. pmc Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis
    Nataliya G Batina
    Department of Industrial and Systems Engineering, University of Wisconsin, 1513 University Avenue, Madison, WI 53706, USA
    Breast Cancer Res Treat 138:519-28. 2013
    ..These differences suggest that targeted prevention and detection strategies that go beyond equalizing access to mammography may be needed to eliminate breast cancer disparities...
  6. pmc Cost-effectiveness of digital mammography breast cancer screening
    Anna N A Tosteson
    The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth Medical School, Lebanon, New Hampshire 03756, USA
    Ann Intern Med 148:1-10. 2008
    ....
  7. doi request reprint Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011
    Natasha K Stout
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts
    JAMA Intern Med 174:114-21. 2014
    ..Low specificity, cost, and little evidence regarding mortality benefits, however, limit recommendations for its use to high-risk women. How breast MRI is actually used in community settings is unknown...
  8. ncbi request reprint Retrospective cost-effectiveness analysis of screening mammography
    Natasha K Stout
    Center for Risk Analysis, Harvard School of Public Health, Boston, MA 02115, USA
    J Natl Cancer Inst 98:774-82. 2006
    ..We performed a retrospective cost-effectiveness analysis comparing actual and alternative screening mammography scenarios...
  9. pmc Keeping the noise down: common random numbers for disease simulation modeling
    Natasha K Stout
    Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Ave, Boston, MA 02115, USA
    Health Care Manag Sci 11:399-406. 2008
    ..We provide a tutorial introduction and demonstrate the application of common random numbers in an individual-level simulation model of the epidemiology of breast cancer...
  10. pmc Modeling the effectiveness of initial management strategies for ductal carcinoma in situ
    Djøra I Soeteman
    Center for Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
    J Natl Cancer Inst 105:774-81. 2013
    ..We sought to quantify the tradeoffs among alternative management strategies for DCIS with respect to disease outcomes and breast preservation...
  11. pmc Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination
    Jeremy D Goldhaber-Fiebert
    Department of Health Policy and Management, Harvard School of Public Health, Boston, USA
    Popul Health Metr 5:11. 2007
    ..S. policy choices for cervical cancer prevention, we developed a model of human papillomavirus (HPV) and cervical cancer, explicitly incorporating uncertainty about the natural history of disease...
  12. pmc Measurement in comparative effectiveness research
    Jessica Chubak
    Group Health Research Institute, Seattle, WA 98101, USA
    Am J Prev Med 44:513-9. 2013
    ....
  13. ncbi request reprint Multiparameter calibration of a natural history model of cervical cancer
    Jane J Kim
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
    Am J Epidemiol 166:137-50. 2007
    ..The authors found that leveraging primary data from longitudinal studies provides unique opportunities for model parameterization of the unobservable nature of HPV infection and its role in the development of cervical cancer...
  14. pmc The effects of indoor environmental exposures on pediatric asthma: a discrete event simulation model
    M Patricia Fabian
    Department of Environmental Health, Boston University School of Public Health, Boston, MA, USA
    Environ Health 11:66. 2012
    ....
  15. pmc Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination
    Jeremy D Goldhaber-Fiebert
    Doctoral Program in Health Policy, Decision Science Concentration, Harvard University, Cambridge, MA, USA
    J Natl Cancer Inst 100:308-20. 2008
    ....